Long-term health effects of COVID-19 in Black and Latino communities
CU-COMMITS (Columbia University Addresses COVID-19 unMet MedIcal Needs to Transform liveS) Study: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
This study is trying to see how COVID-19 has affected the long-term health of Black and Latino individuals and their families, focusing on issues like mental health and heart or lung problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05467930 on ClinicalTrials.gov |
What this trial studies
This study aims to investigate the long-term health outcomes of COVID-19 among predominantly Black and Latinx individuals and their households who were diagnosed with the virus at Columbia University Irving Medical Center. Participants will complete an online questionnaire regarding their current symptoms and health issues, and researchers will review their COVID-related medical history. The study will also invite household members to participate and may collect biological samples from a subset of hospitalized patients to analyze further health impacts. The focus is on understanding complications related to mental health, cardiovascular, pulmonary, and neurological issues following COVID-19 infection.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 18 and older who have a confirmed COVID-19 diagnosis and an electronic medical record at NYP/CUIMC.
Not a fit: Patients under 18 years of age or those who have not been diagnosed with COVID-19 will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term health effects of COVID-19, leading to better care and support for affected communities.
How similar studies have performed: Other studies have explored long-term COVID-19 effects, but this specific focus on Black and Latino communities is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria - Objective 1 Participants: 1. age 18 years and older 2. having an electronic medical record at NYP 3. laboratory confirmed COVID-19 infection diagnosed at NYP/CUIMC after March 1, 2020 or were diagnosed at least 9 months prior to administration of the online questionnaire on long-term outcomes and sequelae. 4. Able to provide informed consent Exclusion Criteria - 1. Index cases less than 18 years of age. 2. Not COVID-19 diagnosed Inclusion Criteria - Objective 2 Participants: 1. age 18 years and older 2. having an electronic medical record at NYP 3. Hospitalized at NYP/CUIMC after March 1 2020, or at least 9 months prior to administration of the online questionnaire on long-term outcomes and sequelae 4. Randomly selected: every 10th index case who was not hospitalized 5. Able to provide informed consent AND 6. Are willing to provide a nasal swab, blood sample in addition to completing the questionnaire.
Where this trial is running
New York, New York
- Columbia University Irving Medical Center — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Magdalena Sobieszczyk, MD, MPH — Columbia University
- Study coordinator: Magdalena Sobieszczyk, MD, MPH
- Email: covid19idresearch@cumc.columbia.edu
- Phone: (845) 372-5023
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.